Invention Grant
- Patent Title: Antitumoral use of cabazitaxel
- Patent Title (中): 卡马西他唑的抗肿瘤用药
-
Application No.: US13456720Application Date: 2012-04-26
-
Publication No.: US08927592B2Publication Date: 2015-01-06
- Inventor: Sunil Gupta
- Applicant: Sunil Gupta
- Applicant Address: FR Antony
- Assignee: Aventis Pharma SA
- Current Assignee: Aventis Pharma SA
- Current Assignee Address: FR Antony
- Agent Kelly L. Bender
- Main IPC: A61K31/337
- IPC: A61K31/337 ; A61K31/573 ; A61K31/164 ; A61K31/56 ; A61K45/06
Abstract:
The invention relates to a compound of formula: which may be in base form or in the form of a hydrate or a solvate, in combination with prednisone or prednisolone, for its use as a medicament in the treatment of prostate cancer, particularly metastatic prostate cancer, especially for patients who are not catered for by a taxane-based treatment.
Public/Granted literature
- US20120301425A1 NOVEL ANTITUMORAL USE OF CABAZITAXEL Public/Granted day:2012-11-29
Information query
